IL115416A0 - Radioactive phosphorus labeling of proteins for radiotherapy - Google Patents

Radioactive phosphorus labeling of proteins for radiotherapy

Info

Publication number
IL115416A0
IL115416A0 IL11541695A IL11541695A IL115416A0 IL 115416 A0 IL115416 A0 IL 115416A0 IL 11541695 A IL11541695 A IL 11541695A IL 11541695 A IL11541695 A IL 11541695A IL 115416 A0 IL115416 A0 IL 115416A0
Authority
IL
Israel
Prior art keywords
radiotherapy
proteins
labeling
radioactive phosphorus
methods
Prior art date
Application number
IL11541695A
Other versions
IL115416A (en
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of IL115416A0 publication Critical patent/IL115416A0/en
Publication of IL115416A publication Critical patent/IL115416A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

32P- and 33P-labeled proteins which are useful for radiotherapy are prepared by stably linking 32P- or 33P- containing molecules to targeting proteins in such a way that the targeting protein retains the ability to bind to a cellular target. Methods for preparing the labeled proteins and their use in methods of radiotherapy are described.
IL11541695A 1994-10-05 1995-09-22 Radioactive phosphorus labeling of proteins for radiotherapy IL115416A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/318,917 US5728369A (en) 1994-10-05 1994-10-05 Radioactive phosphorus labeling of proteins for targeted radiotherapy

Publications (2)

Publication Number Publication Date
IL115416A0 true IL115416A0 (en) 1995-12-31
IL115416A IL115416A (en) 2000-07-26

Family

ID=23240116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11541695A IL115416A (en) 1994-10-05 1995-09-22 Radioactive phosphorus labeling of proteins for radiotherapy

Country Status (9)

Country Link
US (2) US5728369A (en)
EP (1) EP0787138B1 (en)
JP (1) JPH10509425A (en)
AT (1) ATE331728T1 (en)
AU (1) AU3677095A (en)
CA (1) CA2200855C (en)
DE (1) DE69535094T2 (en)
IL (1) IL115416A (en)
WO (1) WO1996011208A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
WO2003056095A1 (en) * 2001-12-27 2003-07-10 Asahi Fiber Glass Co., Ltd. Binder for glass fiber, glass fiber for olefin resin reinforcement, and process for producing olefin resin composition for fiber-reinforced molding
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
ATE477276T1 (en) * 2002-03-01 2010-08-15 Immunomedics Inc INTERNALIZATION OF ANTI CD74 MONOCLONAL ANTIBODIES AND THEIR USES
US7371852B2 (en) * 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
US6893626B2 (en) * 2003-02-18 2005-05-17 Edward T. Wei Compositions for TRP-M8 binding and radioreceptor methods therewith
US7169377B2 (en) 2003-10-15 2007-01-30 Wei Edward T Radioligands for the TRP-M8 receptor and methods therewith
US6887952B1 (en) * 2004-02-12 2005-05-03 Biosite, Inc. N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
EP3546485A1 (en) 2013-05-10 2019-10-02 Whitehead Institute for Biomedical Research In vitro production of red blood cells with sortaggable proteins
US10260038B2 (en) 2013-05-10 2019-04-16 Whitehead Institute For Biomedical Research Protein modification of living cells using sortase
WO2015073746A2 (en) * 2013-11-13 2015-05-21 Whitehead Institute For Biomedical Research 18f labeling of proteins using sortases
US10053683B2 (en) 2014-10-03 2018-08-21 Whitehead Institute For Biomedical Research Intercellular labeling of ligand-receptor interactions
WO2018076833A1 (en) 2016-10-24 2018-05-03 中车长江车辆有限公司 Straddle-type multimodal transport interconnecting system
US10799597B2 (en) 2017-04-03 2020-10-13 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins
GB8906708D0 (en) * 1989-03-23 1989-05-10 Foxwell Brian M J Improvements relating to the radiolabelling of proteins
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins

Also Published As

Publication number Publication date
CA2200855C (en) 2001-04-10
EP0787138A4 (en) 2000-03-08
US5976492A (en) 1999-11-02
JPH10509425A (en) 1998-09-14
DE69535094D1 (en) 2006-08-10
DE69535094T2 (en) 2007-02-01
ATE331728T1 (en) 2006-07-15
IL115416A (en) 2000-07-26
EP0787138A1 (en) 1997-08-06
AU3677095A (en) 1996-05-02
US5728369A (en) 1998-03-17
EP0787138B1 (en) 2006-06-28
WO1996011208A1 (en) 1996-04-18
CA2200855A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
IL115416A (en) Radioactive phosphorus labeling of proteins for radiotherapy
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
EP0679093A1 (en) Methods of delivering agents to target cells.
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
ZA200200789B (en) Multiple cytokine-antibody complexes.
ES2114209T3 (en) HYDRAZINO TYPE RADIONUCLID CHELATORS THAT HAVE A N3S CONFIGURATION.
AU7366687A (en) Coupling agents for radiolabeling proteins
PT762901E (en) PEPTIDES MARKED WITH TECHNOLOGY-99M FOR IMAGIOLOGY.
EP0724456A4 (en) Antibodies to cd40
ATE296312T1 (en) METAL COMPLEX FORMER
AU1062700A (en) Antibody-serum protein hybrids
AU6682598A (en) Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
AU7528894A (en) Hydrazino-type n2s2 chelators
PL319040A1 (en) Modified proteins
WO1999016791A3 (en) Compounds and methods for regulating cell adhesion
AU8040898A (en) Type-1 ribosome-inactivating protein
MY125980A (en) Highly purified cytokine activating factor and methods of use
FI973484A0 (en) Procedure for stimulating an immune system
DE69028094D1 (en) CONJUGATES OF ANTIBODIES WITH VARIABLE DOMAINS
AU2256197A (en) High affinity nucleic acid ligands of complement system proteins
DE59802465D1 (en) METHOD AND KIT FOR IDENTIFYING INTERACTIONS BETWEEN PROTEINS AND Peptides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed